Analysis of Symptom Spectra and Associated Factors Among 536 Respondents During the COVID-19 Epidemic in China: A Cross-Sectional Study

References

• Zheng Z, Peng F, Xu B, et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81(2):e16–e25. doi:10.1016/j.jinf.2020.04.021
   PubMed Web of Science ®Google Scholar
• Lane A, Hunter K, Lee EL, et al. Clinical characteristics and symptom duration among outpatients with COVID-19. Am J Infect Control. 2022;50(4):383–389. doi:10.1016/j.ajic.2021.10.039
   PubMed Web of Science ®Google Scholar
• World Health Organizatio. IHR emergency committee on novel coronavirus; 2019.
   Google Scholar
• National Health Commission of the People’s Republic of China. As of 24:00 on February 23, 2022, the latest situation of the novel coronavirus pneumonia epidemic; 2022.
   Google Scholar
• World Health Organization. Weekly epidemiological update on COVID-19 - 20 April 2023; 2023.
   Google Scholar
• World Health Organization. WHO Coronavirus (COVID-19) Dashboard; 2023.
   Google Scholar
• Chinese Center for Disease Control and Prevention. Situation of Novel coronavirus infection in China; 2020.
   Google Scholar
• Sarkar A, Omar S, Alshareef A, et al. The relative prevalence of the Omicron variant within SARS-CoV-2 infected cohorts in different countries: a systematic review. Hum Vaccin Immunother. 2023;19(1):2212568. doi:10.1080/21645515.2023.2212568
   PubMed Web of Science ®Google Scholar
• Ling MS, Wang CP, Hsieh YL, et al. Emotional disturbance and risk factors among COVID-19 confirmed cases in isolation hotels. Int J Ment Health Nurs. 2023;32(2):469–478. doi:10.1111/inm.13063
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623. doi:10.1016/j.tmaid.2020.101623
   PubMed Web of Science ®Google Scholar
• Chen C, Zhu C, Yan D, et al. The epidemiological and radiographical characteristics of asymptomatic infections with the novel coronavirus (COVID-19): a systematic review and meta-analysis. Int J Infect Dis. 2021;104:458–464. doi:10.1016/j.ijid.2021.01.017
   PubMed Web of Science ®Google Scholar
• World Health Organization. Coronavirus disease (COVID-19): how is it transmitted?; 2021.
   Google Scholar
• Ma Q, Liu J, Liu Q, et al. Global percentage of asymptomatic SARS-CoV-2 infections among the tested population and individuals with confirmed COVID-19 diagnosis: a systematic review and meta-analysis. JAMA Netw Open. 2021;4(12):e2137257. doi:10.1001/jamanetworkopen.2021.37257
   PubMed Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032
   PubMed Web of Science ®Google Scholar
• Shi Y, Wang G, Cai XP, et al. An overview of COVID-19. J Zhejiang Univ Sci B. 2020;21(5):343–360. doi:10.1631/jzus.B2000083
   PubMed Web of Science ®Google Scholar
• Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425–434. doi:10.1016/S1473-3099(20)30086-4
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7
   PubMed Web of Science ®Google Scholar
• Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–481. doi:10.1016/S2213-2600(20)30079-5
   PubMed Web of Science ®Google Scholar
• Day M. Covid-19: four fifths of cases are asymptomatic, China figures indicate. BMJ. 2020;369:m1375. doi:10.1136/bmj.m1375
   PubMed Web of Science ®Google Scholar
• Gao Z, Xu Y, Sun C, et al. A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect. 2021;54(1):12–16. doi:10.1016/j.jmii.2020.05.001
   PubMedGoogle Scholar
• Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348(20):1986–1994. doi:10.1056/NEJMoa030685
   PubMed Web of Science ®Google Scholar
• Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13(9):752–761. doi:10.1016/S1473-3099(13)70204-4
   PubMed Web of Science ®Google Scholar
• Wang S, Niu P, Su Q, et al. Genomic Surveillance for SARS-CoV-2 - China, September 26, 2022 to January 29, 2023. China CDC Wkly. 2023;5(7):143–151. doi:10.46234/ccdcw2023.026
   PubMedGoogle Scholar
• Kariyawasam JC, Jayarajah U, Riza R, Abeysuriya V, Seneviratne SL. Gastrointestinal manifestations in COVID-19. Trans R Soc Trop Med Hyg. 2021;115(12):1362–1388. doi:10.1093/trstmh/trab042
   PubMed Web of Science ®Google Scholar
• Klimek L, Hagemann J, Döge J, et al. Olfactory and gustatory disorders in COVID-19. Allergo J Int. 2022;31(7):243–250. doi:10.1007/s40629-022-00216-7
   PubMedGoogle Scholar
• Borsetto D, Hopkins C, Philips V, et al. Self-reported alteration of sense of smell or taste in patients with COVID-19: a systematic review and meta-analysis on 3563 patients. Rhinology. 2020;58(5):430–436. doi:10.4193/Rhin20.185
   PubMed Web of Science ®Google Scholar
• von Bartheld CS, Hagen MM, Butowt R. Prevalence of chemosensory dysfunction in COVID-19 patients: a systematic review and meta-analysis reveals significant ethnic differences. ACS Chem Neurosci. 2020;11(19):2944–2961. doi:10.1021/acschemneuro.0c00460
   PubMed Web of Science ®Google Scholar
• Aziz M, Goyal H, Haghbin H, Lee-Smith WM, Gajendran M, Perisetti A. The Association of “Loss of Smell” to COVID-19: a systematic review and meta-analysis. Am J Med Sci. 2021;361(2):216–225. doi:10.1016/j.amjms.2020.09.017
   PubMed Web of Science ®Google Scholar
• Song WJ, Hui CKM, Hull JH, et al. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir Med. 2021;9(5):533–544. doi:10.1016/S2213-2600(21)00125-9
   PubMed Web of Science ®Google Scholar
• Fernández-de-Las-Peñas C, Guijarro C, Plaza-Canteli S, Hernández-Barrera V, Torres-Macho J. Prevalence of post-COVID-19 cough one year after SARS-CoV-2 infection: a multicenter study. Lung. 2021;199(3):249–253. doi:10.1007/s00408-021-00450-w
   PubMed Web of Science ®Google Scholar
• Oran DP, Topol EJ. The proportion of SARS-CoV-2 infections that are asymptomatic: a systematic review. Ann Intern Med. 2021;174(5):655–662. doi:10.7326/M20-6976
   PubMed Web of Science ®Google Scholar
• Spinato G, Fabbris C, Polesel J, et al. Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection. JAMA. 2020;323(20):2089–2090. doi:10.1001/jama.2020.6771
   PubMed Web of Science ®Google Scholar
• Barek MA, Aziz MA, Islam MS. Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: a meta-analysis with 55 studies and 10014 cases. Heliyon. 2020;6(12):e05684. doi:10.1016/j.heliyon.2020.e05684
   PubMed Web of Science ®Google Scholar
• Jain V, Yuan JM. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. Int J Public Health. 2020;65(5):533–546. doi:10.1007/s00038-020-01390-7
   PubMed Web of Science ®Google Scholar
• Pan A, Liu L, Wang C, et al. Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan, China. JAMA. 2020;323(19):1915–1923. doi:10.1001/jama.2020.6130
   PubMed Web of Science ®Google Scholar
• Huo D, Yu T, Shen Y, et al. A Comparison of clinical characteristics of infections with SARS-CoV-2 Omicron Subvariants BF.7.14 and BA.5.2.48 - China, October-December 2022. China CDC Wkly. 2023;5(23):511–515. doi:10.46234/ccdcw2023.096
   PubMedGoogle Scholar
• Suzuki R, Yamasoba D, Kimura I, et al. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature. 2022;603(7902):700–705. doi:10.1038/s41586-022-04462-1
   PubMed Web of Science ®Google Scholar
• Chinese Center for Disease Control and Prevention. COVID- 19 clinical and surveillance data--Dec 9, 2022 to Jan 23, 2023, China; 2023.
   Google Scholar
• Liao CX, Wang B, Lyu J, Li LM. 新型冠状病毒Omicron变异株病原学及流行病学研究进展 [Progress in research of etiology and epidemiology of 2019-nCoV Omicron variant]. Zhonghua Liu Xing Bing Xue Za Zhi. 2022;43(11):1691–1698. Chinese. doi:10.3760/cma.j.cn112338-20220929-00829
   PubMedGoogle Scholar